Biotechnology Companies By Working Capital

Working Capital
Working CapitalEfficiencyMarket RiskExp Return
1GMAB Genmab AS
30.66 B
(0.11)
 2.10 
(0.23)
2BNTX BioNTech SE
18.97 B
(0.08)
 2.18 
(0.17)
3REGN Regeneron Pharmaceuticals
16.06 B
 0.25 
 1.11 
 0.27 
4AMGN Amgen Inc
11.94 B
 0.02 
 1.39 
 0.03 
5VRTX Vertex Pharmaceuticals
10.6 B
 0.16 
 2.03 
 0.32 
6MRNA Moderna
7.31 B
 0.08 
 3.94 
 0.31 
7GILD Gilead Sciences
4.8 B
(0.06)
 1.83 
(0.11)
8GLPG Galapagos NV ADR
3.71 B
(0.08)
 1.72 
(0.13)
9BIIB Biogen Inc
3.42 B
(0.05)
 1.70 
(0.08)
10INCY Incyte
3.41 B
 0.06 
 2.03 
 0.12 
11IMAB I Mab
2.97 B
 0.07 
 6.27 
 0.44 
12UTHR United Therapeutics
2.75 B
(0.05)
 1.63 
(0.09)
13GRFS Grifols SA ADR
2.7 B
(0.07)
 5.42 
(0.41)
14ARGX Argenx NV ADR
2.47 B
(0.06)
 3.86 
(0.23)
15BGNE BeiGene
2.39 B
(0.03)
 3.30 
(0.10)
16IONS Ionis Pharmaceuticals
2.19 B
(0.09)
 2.17 
(0.19)
17ALNY Alnylam Pharmaceuticals
2.01 B
(0.05)
 2.61 
(0.14)
18SRPT Sarepta Therapeutics
1.94 B
 0.22 
 3.26 
 0.71 
19CRSP Crispr Therapeutics AG
1.8 B
 0.09 
 4.06 
 0.38 
20BMRN Biomarin Pharmaceutical
1.78 B
(0.08)
 1.53 
(0.12)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.